Diffuse Metastatic Melanoma in the GI Lumen Following Immune Checkpoint Inhibitor Colitis Treatment
We describe the unique case of a 73-year-old man who developed diffuse metastatic melanoma throughout the GI tract following potent immunosuppressive treatment for his immune-mediated colitis. Diagnosis of his metastatic GI luminal disease was confirmed with colonoscopy and EGD biopsies. Immunosuppr...
Main Authors: | Gabriel Sperling, Yinghong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2022-11-01
|
Series: | Case Reports in Gastroenterology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/526649 |
Similar Items
-
Operative management of immune checkpoint colitis following in-transit melanoma: Case report
by: Betzaira G. Childers, et al.
Published: (2023-04-01) -
Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
by: Vera Petrova, et al.
Published: (2020-03-01) -
Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients
by: Vera Petrova, et al.
Published: (2023-02-01) -
Severe Colitis in 2 Patients with Melanoma Treated with BRAF/MEK Inhibitors: Case Report and Literature Review
by: Chloe Wautier, et al.
Published: (2024-02-01) -
Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
by: Hamzah Abu-Sbeih, et al.
Published: (2019-09-01)